Get started
Author

Pad Chivukula

ORCID: 0000-0001-6017-2267
Observed ORCID: 0000-0001-6017-2267
OpenAlex ID: A5112926879
Systemic delivery of factor IX messenger RNA for protein replacement therapy
2017 · Suvasini Ramaswamy, Nina Tonnu, et al. · Proceedings of the National Academy of Sciences · 314
PDF
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
2021 · Ruklanthi de Alwis, Esther S. Gan, et al. · Molecular Therapy · 187
Engineered tRNAs suppress nonsense mutations in cells and in vivo
2023 · Suki Albers, Elizabeth C. Allen, et al. · Nature · 148
PDF
Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials
2024 · Nhân Thị Hồ, Steven G. Hughes, et al. · Nature Communications · 96
PDF
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine
2022 · Jenny G. Low, Ruklanthi de Alwis, et al. · npj Vaccines · 63
PDF
Persistence of immune responses of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2
2024 · Yoshiaki Oda, Yuji Kumagai, et al. · The Lancet Infectious Diseases · 59
PDF
Lipid Nanoparticle-mediated siRNA Transfer Against PCTAIRE1/PCTK1/Cdk16 Inhibits In Vivo Cancer Growth
2016 · Teruki Yanagi, Kiyoshi Tachikawa, et al. · Molecular Therapy — Nucleic Acids · 55
PDF
Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines
2020 · Eric M. Mucker, Priya P. Karmali, et al. · Scientific Reports · 54
PDF
Long Non-coding RNA BGas Regulates the Cystic Fibrosis Transmembrane Conductance Regulator
2016 · Sheena M Saayman, Amanda Ackley, et al. · Molecular Therapy · 40
PDF
12-month persistence of immune responses to self-amplifying mRNA COVID-19 vaccines: ARCT-154 versus BNT162b2 vaccine
2024 · Yoshiaki Oda, Yuji Kumagai, et al. · The Lancet Infectious Diseases · 34
Liver lipopolysaccharide binding protein prevents hepatic inflammation in physiological and pathological non-obesogenic conditions
2022 · Edward Milbank, Ramon Díaz-Trelles, et al. · Pharmacological Research · 26
PDF
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine
2022 · Eugenia Z. Ong, Jia Xin Yee, et al. · npj Vaccines · 20
PDF
A phase 1/2 randomized, double-blinded, placebo controlled ascending dose trial to assess the safety, tolerability and immunogenicity of ARCT-021 in healthy adults
2021 · Jenny G. Low, Ruklanthi de Alwis, et al. · medRxiv · 19
PDF
Downregulation of hepatic lipopolysaccharide binding protein improves lipogenesis-induced liver lipid accumulation
2022 · Jessica Latorre, Ramon Díaz-Trelles, et al. · Molecular Therapy — Nucleic Acids · 14
PDF
A lipid nanoparticle-based oligodendrocyte-specific mRNA therapy
2024 · Masanori Sawamura, Kiyoshi Tachikawa, et al. · Molecular Therapy — Nucleic Acids · 4
Downregulation of peripheral lipopolysaccharide binding protein impacts on perigonadal adipose tissue only in female mice
2022 · Ferran Comas, Ramon Díaz-Trelles, et al. · Biomedicine & Pharmacotherapy · 4
PDF
IT translates: An update on the ARCT-810 mRNA therapy for OTC deficiency
2024 · Markey McNutt, Jerry Vockley, et al. · Molecular Genetics and Metabolism · 1
Interim results of phase 2 trial of ARCT-810 MRNA therapy in patients with ornithine transcarbamylase deficiency
2026 · Ben Greener, Rachael Batabyal, et al. · Molecular Genetics and Metabolism
Works count: 18
Citation count: 1,138
H-index: 14
I10-index: 14
Year
Topic
Type